Mucormycosis resulting in a pseudoaneurysm in the spleen

P C Nevitt1, L Das Narla, E A Hingsbergen

  • 1Medical College of Virginia, Virginia Commonwealth University, Department of Radiology, Richmond 23298-0615, USA.

Pediatric Radiology
|February 24, 2001
PubMed

Insights

Disseminated mucormycosis in a child with acute lymphoblastic leukemia led to a splenic pseudoaneurysm. Successful management involved Amphotericin B and splenectomy, a novel approach for this rare complication.

Area of Science:

  • Mycology
  • Hematology
  • Vascular Surgery

Background:

  • Mucormycosis is a severe fungal infection often fatal in immunocompromised individuals.
  • Tissue infarction and vascular invasion are characteristic of mucormycosis.
  • Disseminated mucormycosis is rare, particularly in pediatric leukemia patients.

Observation:

  • A 16-year-old with acute lymphoblastic leukemia developed disseminated mucormycosis.
  • The infection resulted in a pseudoaneurysm of the spleen.
  • This specific presentation has not been previously documented in medical literature.

Findings:

  • Successful treatment combined systemic antifungal therapy with Amphotericin B and surgical intervention (splenectomy).
  • This multidisciplinary approach effectively managed the splenic pseudoaneurysm secondary to mucormycosis.
  • The case highlights a previously undescribed complication and treatment strategy.

Implications:

  • This case expands the understanding of mucormycosis complications in pediatric leukemia.
  • It suggests that a combination of antifungal therapy and surgery can be effective for splenic pseudoaneurysms caused by mucormycosis.
  • Further research may explore this treatment paradigm for similar rare presentations.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...